GSK3B and sarcoma: In sarcoma cells, we found reductions in the protein levels of positive effectors of the Wnt pathway (β-catenin, TCF4, c-MYC and WNT1) and increases in those of negative effectors (GSK3-β and AXIN1) in cells overexpressing EMX proteins.